000 | 01178 a2200325 4500 | ||
---|---|---|---|
005 | 20250514070911.0 | ||
264 | 0 | _c20030612 | |
008 | 200306s 0 0 eng d | ||
022 | _a0098-7484 | ||
024 | 7 |
_a10.1001/jama.289.21.2865 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLauner, Lenore J | |
245 | 0 | 0 |
_aNonsteroidal anti-inflammatory drugs and Alzheimer disease: what's next? _h[electronic resource] |
260 |
_bJAMA _cJun 2003 |
||
300 |
_a2865-7 p. _bdigital |
||
500 | _aPublication Type: Comment; Editorial | ||
650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 | _aCyclooxygenase 1 |
650 | 0 | 4 | _aCyclooxygenase 2 |
650 | 0 | 4 | _aCyclooxygenase 2 Inhibitors |
650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsoenzymes _xantagonists & inhibitors |
650 | 0 | 4 | _aMembrane Proteins |
650 | 0 | 4 |
_aProstaglandin-Endoperoxide Synthases _xmetabolism |
773 | 0 |
_tJAMA _gvol. 289 _gno. 21 _gp. 2865-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.289.21.2865 _zAvailable from publisher's website |
999 |
_c12569481 _d12569481 |